Gelling Fiber Dressings Market Scope
Wound management is one of the most important concerns in any healthcare setting. Gelling fibres are now preferred over traditional alginate fibres in wound care. Gelling fibres are soft, comfortable, non-woven absorbent wound covers that aid in the management of wound drainage as well as the removal of damaged, dead, and infected tissues. The gelling fibre dressing absorbs wound fluid, resulting in the formation of a gel that aids in the maintenance of a moist environment required for wound healing and the formation of new tissues. Gelling Fibres can retain and control the exudate level, lowering the risk of peri-wound maceration and other infections. Gelling fibres, unlike other dressing fibres, can conform to varying wound shapes and can be removed in one piece.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Key Companies Profiled | DermaRite Industries, LLC. (United States), Mölnlycke Health Care AB (Sweden), Cardinal Health (United States), Smith & Nephew (United Kingdom), Gentell Corp. (United States), ConvaTec Inc. (United Kingdom), Crawford Healthcare Limited (United Kingdom), Safe n' Simple (United States), 3M (United States) and BSN Medical (Germany) |
CAGR | % |
To entice more end users, market players are focusing on providing Gelling Fiber Dressing with higher quality while adhering to all regulatory standards. In the global Gelling Fiber Dressing market, there are numerous large and small-scale service providers. They are also concentrating on the implementation of numerous advanced technologies in the development of better scents. Furthermore, the numerous industry profits have led to the entry of new players, raising the level of rivalry in an already competitive market. The Gelling Fiber Dressing market is currently expanding due to the rapid advancement of technology. Some of the key players in this market follow strategies, which include new product offerings, product approvals, partnerships and alliances, mergers and acquisitions, and business expansions. Research Analyst at AMA estimates that United Kingdom Players will contribute to the maximum growth of Global Gelling Fiber Dressings market throughout the predicted period.
DermaRite Industries, LLC. (United States), Mölnlycke Health Care AB (Sweden), Cardinal Health (United States), Smith & Nephew (United Kingdom), Gentell Corp. (United States), ConvaTec Inc. (United Kingdom), Crawford Healthcare Limited (United Kingdom), Safe n' Simple (United States), 3M (United States) and BSN Medical (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Acelity (United States), Medline Industries (United States), DeRoyal Industries (United States), Paul Hartmann (Germany) and Winner medical (China).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Gelling Fiber Dressings market by Type and Region with country level break-up.
On the basis of geography, the market of Gelling Fiber Dressings has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2021.
Market Leaders and their expansionary development strategies
In March 2021 Cardinal Health today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately USD 1 billion, which includes the buyer's assumption of certain liabilities and seller's retention of certain working capital accounts. The transaction is expected to close in the first half of Cardinal Health's fiscal year 2022, subject to customary closing conditions and regulatory clearances.
Winner Medical, a top OEM&ODM advanced wound care dressing manufacturer, showcased its full set of advanced wound care solutions at EWMA 2022 which was scheduled in May 2022 in Paris, France. Winner Medical displayed its innovative wound care products that provide optimal care for patients.
Alginate Or Other Fiber Gelling Dressing (A6196-A6199) Alginate or other fiber gelling dressing covers are covered for moderately to highly exudative full thickness wounds (e.g., stage 3 or 4 ulcers); and alginate or other fiber gelling dressing fillers for moderately to highly exudative full thickness wound cavities (e.g., stage 3 or 4 ulcers). They are not reasonable and necessary on dry wounds or wounds covered with eschar. Dressing change is up to once per day. One wound cover sheet of the approximate size of the wound or up to 2 units of wound filler (1 unit = 6 inches of alginate or other fiber gelling dressing rope) are used at each dressing change.
Gelling Fiber Dressings Market Dynamics:
Attributes | Details |
---|
Trends Influencing Market | - The Growing Technological Advancement in Fiber Dressing.
|
Key Restraints | - Availability of Substitutes will Hinder the Market Growth.
|
Challenges | - The Requirement for Having another Secondary Dressing.
|
Market Opportunities | - The Growing Medical Industry and Surgical Technology will be Bringing More Opportunities to Market.
|
Key Target Audience
Pharmaceutical companies, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others